SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility driven by intense debate over its massive debt, heavy AI infrastructure capital expenditures, and the sustainability of its large-scale cloud backlog. While some investors are aggressively buying the dip, viewing the stock as oversold and strategically essential to the AI ecosystem, others remain deeply skeptical due to the company's financial leverage and persistent downward price momentum.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is facing intense volatility as investors weigh a recent short-seller report questioning its supply chain against major institutional endorsements and multibillion-dollar project agreements. The community remains deeply divided, with some traders actively looking to accumulate shares during the pullback while others express frustration over the stock's recent decline and the influence of aggressive short-selling.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as investors weigh strong delivery numbers and new government contracts against ongoing concerns about production timelines and regulatory certification milestones. While some in the community see the stock as a deeply undervalued recovery play, others are frustrated by persistent volatility and sentiment-driven price swings that keep the ticker trading in a stubborn range.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending due to heightened volatility and frustration from retail investors regarding its persistent underperformance compared to the broader fintech sector. The community is actively debating the stock's future, highlighting concerns over management's long-term vision versus short-term price action, while monitoring key technical support levels and high short interest.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense market volatility and increased short interest, even as the company highlights strong long-term AI infrastructure demand and multi-year cloud contracts. Investors remain divided, with many debating the impact of management's expansion strategy and capacity execution against the stock's recent sharp decline.

Hut 8 Corp. engages in the development and operation of data centers at scale, supporting AI, high-performance computing (HPC), ASIC compute, and other energy-intensive technology applications. It operates through the following segments: Power, Digital Infrastructure, Compute, and Others. The Power segment manages the origination, development, and management of powered land and energy infrastructure. The Digital Infrastructure refers to the development, ownership, and operation of facilities designed to support next-generation, energy-intensive technology application. The Compute segment deals with operating businesses that deploy and monetize compute assets across next-generation energy-intensive technology. The Others segment offers equipment sales and repairs. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is currently at the center of investor discussion following the commercialization of its massive Beacon Point data center campus, which features a multi-billion dollar, 15-year lease agreement with a major investment-grade tenant. While community sentiment remains split between excitement over the company's aggressive expansion into AI infrastructure and frustration over recent stock volatility, traders are intensely focused on whether these long-term contracts provide enough conviction to break through current resistance levels and sustain a broader valuation re-rating.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors monitor ongoing frustration with leadership communication and share price stagnation while searching for signals regarding the company's proprietary combination vaccine and potential licensing partnerships. The community remains deeply divided, with some betting on future value from Matrix-M technology licensing, while others express intense dissatisfaction with executive compensation and the lack of updates on major assets.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently trending as shareholders react to the definitive agreement for Tempus AI to acquire the company for $1.5 billion, with community sentiment divided between disappointment over the offer price and active debate regarding the potential for competing bidders or deal termination risks. Discussions are focused on the integration of Personalis' MRD technology into Tempus' AI-driven oncology platform and the strategic implications for existing partnerships with major pharmaceutical firms.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is currently attracting intense market interest driven by excitement over its lead BCMA-targeting CAR-T asset, NXC-201, which is showing high clinical efficacy in relapsed/refractory AL amyloidosis. The community is actively discussing the stock's potential for acquisition, favorable regulatory tailwinds under updated FDA guidelines, and the strategic hiring of experienced leadership to potentially transition the company into a commercial-stage powerhouse.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin shareholders are bracing for pivotal developments as the company heads toward an upcoming annual general meeting amidst widespread retail investor discontent over stagnant performance. Market attention is heavily focused on the looming Supreme Court hearing regarding the Hikma litigation, alongside intense community debate about the potential for future product formulations and long-term M&A viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tamara A Favorito Expands Holdings With $51K Zevra Therapeutics Stock Options Acquisition

A notable acquisition unfolded on June 18, as Favorito, Director at Zevra Therapeutics (NASDAQ:ZVRA), reported the acquisition of stock options for 30,000 shares in an SEC filing.
What Happened: A Form 4 filing from theread more...

Corey M. Watton Seizes Opportunity: Acquires $51K Worth Of Zevra Therapeutics Stock Options

In a recent SEC filing, it was disclosed that Corey M. Watton, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), made a noteworthy acquisition of company stock options on June 18,.
What Happened: A Form 4 filing fromread more...

A Noteworthy Decision By Thomas Anderson As Acquires $51K In Zevra Therapeutics Stock Options

In a new SEC filing on June 18, it was unveiled that Anderson, Director at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: Uncovered in a Form 4 filing on Thursday with theread more...

Alicia Secor Takes A Bullish Stance, Acquiring $51K Worth Of Zevra Therapeutics Stock Options

A noteworthy insider acquisition was disclosed on June 18, as Secor, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), reported the acquisition of stock options for 30,000 shares.
What Happened: Uncovered in a Form 4read more...

Douglas W Calder Makes Strategic Play: Invests $51K In Zevra Therapeutics Stock Options

In a new SEC filing on June 18, it was unveiled that Calder, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: Calder, Board Member at Zevra Therapeutics,read more...

Big News: Alvin Shih Adds $51K In Zevra Therapeutics Stock Options Io Portfolio

In a new SEC filing on June 18, it was unveiled that Shih, Board Member at Zevra Therapeutics (NASDAQ:ZVRA), acquired stock options for 30,000 shares.
What Happened: In a recent Form 4 filing with the U.S. Securitiesread more...

ZVRA Stock Hits Its Highest Levels In Nearly 5 Years – What’s Driving This Sharp Rally Today?

Equity

Zevra Therapeutics shares saw a series of positive brokerage actions after the company asked the U.S. Food and Drug Administration to add a new patent for its Miplyffa drug to the Orange Book.

ZVRA Stock ‘Way Undervalued’? Analyst Sees 117% Upside After Patent Extends Exclusivity Till 2041 For Sole Approved Drug

Zevra said in a statement that it has asked the U.S. Food and Drug Administration to add its new patent for its drug MIPLYFFA to its official list.


Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass Estimates

Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of +184.36% and +15.51%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates

Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -29.46% and -15.29%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Neutral Sentiment

Long-term growth with defined downside

Reliable income

Digital asset exposure

Portfolio resilience

Which of the following best describes the primary outcome you are seeking from an ETF investment? 
 
*Sponsored by Calamos and S&amp;P Global

Stocktwits

Which of the following best describes the primary outcome you are seeking from an ETF investment? 
 
*Sponsored by Calamos and S&P Global

Stocktwits Polls

Traders are closely monitoring the July 21st oral explanation hearing as a pivotal step in the ongoing European regulatory review process.

Discussions are heating up over historical regulatory success rates and whether the drug's strong Adcom history signals a likely positive opinion.

Investors are navigating choppy price action and end-of-day selling pressure while waiting for clear regulatory catalysts.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ZVRAZevra Therapeutics Inc

Fundamentals

Latest ZVRA News